Clinical Operations in Oncology Trials Europe 2017, December 5-6, 2017
FREMONT, CA: The Clinical Operations in Oncology Trials Europe 2017 is scheduled for 5th and 6th December 2017, Munich, Germany. The 2016 Clinical Operations in Oncology Trials Europe conference was a thought-provoking two days of engaging presentations from the most innovative oncology companies in the industry.
The focused, senior-level audience debated how to improve operational efficiencies in oncology trials to protect product pipeline and rise above the competition. The 2016 agenda was an exciting mix of panels, roundtables and case study presentations with representation from leading biopharma companies such as Eli Lilly, Astrazeneca and Abbvie.
Following on from this success, Arena International is pleased to announce that this unique event will be returning once again in December 2017.
The 2017 program will stay abreast of the latest advances in trial design, patient recruitment and monitoring in global oncology trials. If you have an interesting topic proposal or case study, please get in touch with the programme director.
By Deborah Gash, VP & CIO, Saint Luke’s Health System
By Setrag Khoshafian, Chief Evangelist & VP of BPM...
By Sam Talbot, Director, Worldwide Service, Otis Elevator
By Darrin Whitney, CIO, GENBAND
By Chris Mandel, SVP-Strategic Solutions, Sedgwick
By Rick Schooler, VP & CIO, Orlando Health
By Wes Wright, CTO, Sutter Health
By Jenny Watson, VP-Digital Marketing & Direct, AutoNation
By Arnold Leap, CIO, 1-800-Flowers.com
By Rob Klopp, CIO & Deputy Commissioner-Systems, Social...
By Bill Schimikowski, VP, Customer Experience, Fidelity...
By Tim Porzio, VP-Operations & Infrastructure, IS&T, Sodexo...
By Robert Roser, CIO, Fermilab
By Kevin Kometer, CIO, CME Group
By Joseph Eng, CIO, TravelClick
By Merijn te Booij, CMO, Genesys
By Matt Schlabig, CIO, Worthington Industries
By John Boden, Vice President of Information and Member...
By Christy Hartner, SVP, Commerce Bank
By Greg Toornman, VP, Global Materials, Logistics, and...